Literature DB >> 21071735

Assessment of the contribution of cytokine plasma levels to detect retinopathy of prematurity in very low birth weight infants.

Rita C Silveira1, Joao B Fortes Filho, Renato S Procianoy.   

Abstract

PURPOSE: To prospectively study the association of high cytokine plasma levels with later development of retinopathy of prematurity (ROP) in preterm infants with early-onset sepsis to assess a laboratory test to detect ROP.
METHODS: A prospective cohort study was conducted of preterm infants with clinical early-onset sepsis whose birth weight (BW) was ≤1500 g and gestational age (GA) was ≤32 weeks. Plasma samples were assayed for cytokines IL-6, IL-8, IL-10, IL-1β, and TNF-α. ROP was diagnosed in screening assessments. For the univariate analysis of the known risk factors for ROP, all infants without ROP were designated as the No ROP group, patients with any stage of ROP formed the ROP group, and all treated patients formed the Severe ROP group. The best cutoff points for all cytokine levels were determined by ROC curves.
RESULTS: Seventy-four patients were enrolled. Mean GA and BW were 29.6 ± 2.1 weeks and 1110.3 ± 232.5 g, respectively; 49 patients (66.2%) had no ROP and 25 (33.8%) had any stage of ROP (17 had stage 1 or 2 ROP and 8 had stage 3 ROP). IL-6 >357 pg/mL, IL-8 >216 pg/mL, and TNF-α >245 pg/mL were significantly associated with treatable ROP.
CONCLUSIONS: There is a relationship between high plasma levels of IL-6, IL-8, and TNF-α in the first days of life with the later development of ROP severe enough to treat in preterm infants with early-onset sepsis. Further epidemiologic studies are needed to explore other possible associations of high serum levels of cytokines with ROP in this population at high risk.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21071735     DOI: 10.1167/iovs.10-6279

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  23 in total

1.  [Pharmacological treatment for retinopathy of prematurity].

Authors:  A Stahl; H Agostini; C Jandeck; W Lagrèze
Journal:  Ophthalmologe       Date:  2011-08       Impact factor: 1.059

2.  Influence of polymorphisms in VEGF, ACE, TNF and GST genes on the susceptibility to retinopathy of prematurity among Chinese infants.

Authors:  Xiao-Jun Lei; Yong-Xia Zhao; Tong Qiao
Journal:  Int J Ophthalmol       Date:  2018-09-18       Impact factor: 1.779

Review 3.  Perinatal infection, inflammation, and retinopathy of prematurity.

Authors:  Jennifer Lee; Olaf Dammann
Journal:  Semin Fetal Neonatal Med       Date:  2011-09-07       Impact factor: 3.926

4.  Characteristic clinical features associated with aggressive posterior retinopathy of prematurity.

Authors:  Y J Ahn; K E Hong; H R Yum; J H Lee; K S Kim; Y A Youn; S H Park
Journal:  Eye (Lond)       Date:  2017-02-24       Impact factor: 3.775

Review 5.  Retinopathy of prematurity: contribution of inflammatory and genetic factors.

Authors:  Mariza Fevereiro-Martins; Hercília Guimarães; Carlos Marques-Neves; Manuel Bicho
Journal:  Mol Cell Biochem       Date:  2022-03-09       Impact factor: 3.396

6.  Association of inflammatory and angiogenic biomarkers in maternal plasma with retinopathy of prematurity in preterm infants.

Authors:  Jae Shin Song; Se Joon Woo; Kyo Hoon Park; Hunmin Kim; Kyong-No Lee; Yu Mi Kim
Journal:  Eye (Lond)       Date:  2022-09-15       Impact factor: 4.456

Review 7.  Retinal Vasculature in Development and Diseases.

Authors:  Ye Sun; Lois E H Smith
Journal:  Annu Rev Vis Sci       Date:  2018-09-15       Impact factor: 6.422

8.  Late Enteral Feedings Are Associated with Intestinal Inflammation and Adverse Neonatal Outcomes.

Authors:  Yelizaveta Konnikova; Munir M Zaman; Meher Makda; Danila D'Onofrio; Steven D Freedman; Camilia R Martin
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

9.  The genetics of retinopathy of prematurity: a model for neovascular retinal disease.

Authors:  Ryan Swan; Sang Jin Kim; J Peter Campbell; R V Paul Chan; Kemal Sonmez; Kent D Taylor; Xiaohui Li; Yii-Der Ida Chen; Jerome I Rotter; Charles Simmons; Michael F Chiang
Journal:  Ophthalmol Retina       Date:  2018-03-08

10.  Neonatal hyperglycemia inhibits angiogenesis and induces inflammation and neuronal degeneration in the retina.

Authors:  Elsa Kermorvant-Duchemin; Alexis Christophe Pinel; Sophie Lavalette; Delphine Lenne; William Raoul; Bertrand Calippe; Francine Behar-Cohen; José-Alain Sahel; Xavier Guillonneau; Florian Sennlaub
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.